Meanwhile, when the false negative results due to low sensitivity come from low tumor content, trimming or macro‐ and microdissection may be useful to eliminate nontumor cells, and EGFR‐TKI would be effective on the tumors. The gene discussed is EGFR; the disease is neoplasm.